Clinical Trials Directory

Trials / Unknown

UnknownNCT01981421

Usefulness of Multi-parametric, Quantitative MR Imaging for Staging of Hepatic Fibrosis in the Patients With Chronic Hepatitis

Status
Unknown
Phase
Study type
Observational
Enrollment
60 (estimated)
Sponsor
Yonsei University · Academic / Other
Sex
All
Age
19 Years – 80 Years
Healthy volunteers
Not accepted

Summary

Liver fibrosis has been considered as irreversible change. However, recent study showed that early stage liver fibrosis could be reversible and a lot of new drugs are now developing or developed including anti-viral treatment. Liver biopsy is considered as golden standard for the evaluation of liver fibrosis. But biopsy specimen through biopsy only consists of 1/50000 of the whole liver and heterogeneity of liver fibrosis, accurate diagnosis of liver fibrosis is still challenging. Furthermore, its invasive nature, repeated biopsy is practically almost impossible. Hence, non-invasive diagnosis of liver fibrosis is important. In this study we hypothesized that multi-parametric MR imaging including MR elastography, conventional DWI, and IVIM can predict changes of liver stiffness after anti-viral therapy in patients with chronic liver disease. We will enroll 60 biopsy-proven patients and perform multi-parametric MR imaging at the enrollment and one year later to evaluate changes in quantitative values in MR.

Conditions

Timeline

Start date
2013-06-01
Primary completion
2015-12-01
Completion
2015-12-01
First posted
2013-11-11
Last updated
2013-11-11

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT01981421. Inclusion in this directory is not an endorsement.